Older Coverage
stories 241–300 of 633Nvidia's Moat Moves From Silicon to Its Balance Sheet
With AMD and Google narrowing Nvidia's technology lead, the company is deploying its balance sheet instead -- a $500 billion GPU financing pact with Wall Street, a $105 billion OpenAI backstop and $30.2 billion in equity holdings.
Tesla Readies a Public Cybercab Launch in Austin
Tesla Readies a Public Cybercab Launch in Austin
Tesla is planning a public launch of the Cybercab in Austin as soon as this month, according to The Information, though the two-seater without a steering wheel or pedals has often been spotted testing with both installed.
Rare-Earth Miner Tactical Resources Hits Nasdaq
Rare-Earth Miner Tactical Resources Hits Nasdaq
Tactical Resources began trading on the Nasdaq under ticker TREO on August 18 via a SPAC merger with Plum Acquisition Corp. III, positioning the company to process rare-earth tailings in Texas as US critical-minerals policy intensifies.
Kraken's Krak App Launches a 2% Cash-Back Debit Card
Kraken's Krak App Launches a 2% Cash-Back Debit Card
Kraken's Krak money app launched a US debit card paying up to 2% back in cash or bitcoin, spendable from more than 600 currencies and crypto assets converted at the point of purchase.
SpaceX Tows an Intact Starship to Christmas Island
SpaceX Tows an Intact Starship to Christmas Island
SpaceX recovered an intact Starship after a 24-day tow across the Indian Ocean to Christmas Island, the first time a ship survived splashdown without disintegrating and the first chance to inspect flown heat shield hardware.
Two New Aerospace SPACs Price $300M in Combined IPOs
Two New Aerospace SPACs Price $300M in Combined IPOs
Karman Line Acquisition Corp and NorthStrive Acquisition Corp I priced a combined $300 million in blank-check IPOs targeting aerospace, defense and industrial manufacturing.
Pony AI's Robotaxi Revenue Jumps 691% in Q2
Pony AI's Robotaxi Revenue Jumps 691% in Q2
Pony AI reported Q2 revenue up 69% to $36.2 million, with robotaxi service revenue up 691% to a record $12.1 million as its fleet grew to 2,000 vehicles and Uber committed to more than 4,000 robotaxis across international markets including Europe.
ECB Economists Say an AI Valuation Correction Is Likely
ECB Economists Say an AI Valuation Correction Is Likely
European Central Bank economists wrote that research on past technological revolutions points to a likely correction in current stock valuations, with the drawdown arriving whether or not investors are being irrational about AI.
Korean Retail Investors Pile Into US Stocks
Korean Retail Investors Pile Into US Stocks
South Korean retail investors made $4.5 billion in net purchases of US securities in July, part of $73.6 billion in 2025 alone, as domestic market volatility pushes 'ant investors' toward US equities and leveraged semiconductor ETFs.
CXMT's Rise to China's Most Valuable Firm, Explained
CXMT's Rise to China's Most Valuable Firm, Explained
Memory chipmaker CXMT overtook Tencent as China's most valuable listed company just weeks after a 466% IPO debut, putting a number on how central memory chips have become to China's AI buildout.
OpenAI's Revenue Run-Rate Doubles to $40B Pre-IPO
OpenAI's Revenue Run-Rate Doubles to $40B Pre-IPO
OpenAI's revenue run-rate has topped $40 billion, roughly double where it stood at the end of 2025, sharpening the case for its Wall Street debut even as the risks Pulse flagged in its IPO warning coverage remain unresolved.
The IPO Window Is Open for Four Companies, Not Forty
The IPO Window Is Open for Four Companies, Not Forty
The 2026 tech listing boom is real in aggregate and concentrated in practice: a handful of megacap names carry the volume while the median venture-backed company still cannot clear the bar underwriters are setting.
AI's Best Exits Are Trades, Not Listings
AI's Best Exits Are Trades, Not Listings
Stripe's $7 billion purchase of OpenRouter, SpaceX's Cursor deal and consolidation among eVTOL makers point to strategic acquisition replacing the public offering as the primary liquidity path for AI-era companies.
Reddit Joins the S&P 500 on a Stunning Turnaround
Reddit Joins the S&P 500 on a Stunning Turnaround
Reddit joins the S&P 500 before markets open on August 18, becoming only the second pure-play social media company in the index after Meta, following a stock rally triggered by the inclusion announcement.
This Week's IPO Filings Are Mostly Small Shells
This Week's IPO Filings Are Mostly Small Shells
Eight S-1-family filings hit the SEC between August 13 and 17, and none are venture-scale tech debuts -- a reminder that most weeks in an active IPO year still produce shell registrations and small financials, not headline listings.
What's Left in the 2026 IPO Pipeline
What's Left in the 2026 IPO Pipeline
SpaceX's $1.77 trillion June debut made Q2 2026 the biggest quarter for U.S. IPOs on record, and OpenAI and Anthropic are both racing toward their own public listings before year-end -- the two biggest names left in a pipeline that's otherwise thinning out.
Cooling Inflation, Intel Raise Lift the AI Trade
Cooling Inflation, Intel Raise Lift the AI Trade
A cooler-than-expected inflation report and Intel upsized $20 billion stock sale helped push the odds of a Fed hold at the September meeting to 67%, up from 55%, a backdrop that matters for how pending mega-IPOs get priced this fall.
The 2026 IPO Class Scorecard: Who's Actually Winning
The 2026 IPO Class Scorecard: Who's Actually Winning
A hot IPO window doesn't guarantee a hot stock afterward -- Cerebras is down sharply on its second earnings report even after raising guidance, while Reddit and SanDisk show post-listing performance hinges on execution, not debut pricing.
US IPO Proceeds Are Running 7x Ahead of 2025
US IPO Proceeds Are Running 7x Ahead of 2025
SEC data shows traditional US IPOs raised roughly $114.1 billion through June 30, more than seven times the $14.8 billion raised over the same period in 2025, spread across AI infrastructure, industrials, healthcare and consumer sectors.
Anthropic Backers Model a $2-3 Trillion October IPO
Anthropic Backers Model a $2-3 Trillion October IPO
Anthropic investors are modeling a $2 trillion IPO valuation for October, with some projecting as high as $3 trillion, based on annualized revenue expected to reach $100 billion to $120 billion by year-end.
SharonAI Amends IPO Filing as Neocloud IPO Wave Builds
SharonAI Amends IPO Filing as Neocloud IPO Wave Builds
SharonAI Holdings, an Australian neocloud operator partnering with Nvidia on GPU clusters, filed an amended S-1 registering $691.7 million in convertible notes and 26 million resale shares as it builds out AI data center capacity.
Anthropic Reportedly Plans $2 Trillion IPO for October
Anthropic Reportedly Plans $2 Trillion IPO for October
Anthropic is preparing a stock listing that investors and bankers believe could value the company near $2 trillion as soon as October, the largest public offering in history and more than double its last private mark of $965 billion.
Six Companies Filed for US Listings This Week: The S-1 Rundown
Six Companies Filed for US Listings This Week: The S-1 Rundown
At least six companies filed IPO paperwork with the SEC on August 12, spanning AI infrastructure, biopharma, fintech and minerals -- a reminder the listing pipeline stays busy behind mega-IPO headlines like Anthropic's.
Unitree's $9B IPO Subscription Closes, Debut Set for Late August
Unitree's $9B IPO Subscription Closes, Debut Set for Late August
Unitree's STAR Market IPO subscription window closed Wednesday after pricing at 150.80 yuan a share and a $9 billion valuation, with the humanoid robot maker's Shanghai trading debut now expected between August 17 and 21.
Robinhood's YC-Linked Retail Fund Nears NYSE Debut
Robinhood's YC-Linked Retail Fund Nears NYSE Debut
Robinhood Ventures Fund II, a closed-end fund giving retail investors exposure to 80 early-stage startups linked to Y Combinator, closes its share-request window August 12 ahead of a planned NYSE debut at $25 a share on August 13.
Chinese Copper Foil Maker Londian Wason Preps NYSE Debut
Chinese Copper Foil Maker Londian Wason Preps NYSE Debut
Londian Wason New Energy Tech, a Shenzhen-based electrolytic copper foil producer for EV batteries, set terms to raise $75 million on the NYSE under ticker FOIL, with pricing expected around August 12.
Biotech IPO Window Closes Its Strongest Week Since Spring
Biotech IPO Window Closes Its Strongest Week Since Spring
BlossomHill and Latigo Biotherapeutics both closed upsized IPOs by August 10, capping a four-deal stretch that also included Braveheart Bio and Attovia Therapeutics pricing above or near the top of their ranges.
Unitree's STAR Market IPO Subscription Opens at $9B
Unitree's STAR Market IPO Subscription Opens at $9B
Unitree's Shanghai STAR Market IPO subscription formally opened at a roughly $9 billion valuation, the first profitable, scaled humanoid robotics company to go public on a major exchange.
Attovia Therapeutics Climbs 29% After $289M IPO
Attovia Therapeutics Climbs 29% After $289M IPO
Attovia Therapeutics priced an upsized $289 million IPO and climbed 29% on debut, the fourth biotech in two weeks to price well above its original terms.
Caris Leads a Wild Week for Recent IPO Stocks
Caris Leads a Wild Week for Recent IPO Stocks
Caris Life Sciences jumped 21.6% on a beat-and-raise quarter while BillionToOne fell 29.8% despite beating estimates, the sharpest split in the Renaissance IPO Index in weeks.
BillionToOne's Selloff Is a Warning for Biotech IPOs
BillionToOne's Selloff Is a Warning for Biotech IPOs
BillionToOne beat Q2 estimates by a wide margin and still fell nearly 30% because it reiterated rather than raised guidance -- a signal about how little room newly public companies have left to disappoint.
What BofA's Extreme Bull Signal Means for Your Marks
What BofA's Extreme Bull Signal Means for Your Marks
BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.
Biotech IPOs Are Pricing Above Range Again
Biotech IPOs Are Pricing Above Range Again
BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.
Latigo Biotherapeutics Jumps 17% in $345.6M IPO
Latigo Biotherapeutics Jumps 17% in $345.6M IPO
Latigo Biotherapeutics priced its upsized IPO at $18 a share for $345.6 million and jumped 17% in its Nasdaq debut, the third biotech offering in two weeks to price above range.
Wall Street Rallies on Weak Jobs Data as Software Earnings Beat
Wall Street Rallies on Weak Jobs Data as Software Earnings Beat
A weak July jobs report sent stocks to a broad rally on rate-cut bets, with Atlassian and Twilio posting blowout earnings beats -- even as Bank of America's own sentiment gauge hit its most bullish reading since 2021.
SpaceX Swings From Post-Earnings Drop to 16% Rally
SpaceX Swings From Post-Earnings Drop to 16% Rally
SpaceX stock fell 8% after a Q2 earnings beat spooked investors on capex, then rallied 15.83% three days later as its first lockup expiration passed without heavy selling and the Cursor deal stayed on track.
BofA's Sell Signal Hits Highest Level Since 2021
BofA's Sell Signal Hits Highest Level Since 2021
Bank of America's Bull & Bear sentiment indicator jumped to 9.7 -- its highest reading since 2021 and above the firm's own 8.0 sell-signal threshold -- even as the S&P 500 and Nasdaq both rallied Friday on weak jobs data.
Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat
Atlassian Stock Jumps 36% on Cloud, AI Earnings Beat
Atlassian shares surged as much as 35.6% after fiscal Q4 revenue beat estimates by $100M+ on 31% cloud growth, with co-founder Mike Cannon-Brookes pledging to personally buy up to $250M of stock.
Cloudflare Stock Jumps 15% on Earnings Beat
Cloudflare Stock Jumps 15% on Earnings Beat
Cloudflare shares jumped as much as 17% after beating Q2 estimates and raising full-year guidance, with AI-driven demand for network security and infrastructure cited as the key growth driver.
BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.
Braveheart Bio Prices Upsized $382.5M IPO on Nasdaq
Braveheart Bio Prices Upsized $382.5M IPO on Nasdaq
Braveheart Bio priced its IPO at $18 a share, above range, raising $382.5M for a cardiovascular drug licensed from China's Hengrui Pharmaceuticals -- a sign the biotech IPO window is reopening after two rough years.
SpaceX's Rocky Unlock Is a Warning for OpenAI
SpaceX's Rocky Unlock Is a Warning for OpenAI
SpaceX shares are trading near $108, down more than half from their post-IPO high, just as the first of four straight monthly unlock events begins -- a live case study for OpenAI and Anthropic on what happens once lockups start expiring.
Unitree Prices IPO at $9B on Shanghai Market
Unitree Prices IPO at $9B on Shanghai Market
Unitree Robotics priced its Shanghai STAR Market IPO at 150.80 yuan a share, raising roughly $904 million and valuing China's first publicly traded humanoid robot maker at about $9 billion.
SK Hynix Plunges 10% in Asian Tech Selloff
SK Hynix Plunges 10% in Asian Tech Selloff
SK Hynix fell nearly 10% and Samsung dropped over 6% as Asian tech stocks tracked a Wall Street AI-name selloff, the second sharp chip-sector drop in the Korean chipmaker's shares in two weeks.
Vogenx Prices $68M IPO for Metabolic Drug
Vogenx Prices $68M IPO for Metabolic Drug
Vogenx priced 6.25M shares at $12 to raise roughly $68M net, funding development of mizagliflozin, an SGLT1 inhibitor for gastrointestinal and metabolic disorders, through 2028.
Braveheart Bio Prices $300M IPO for Heart Drug
Braveheart Bio Prices $300M IPO for Heart Drug
Braveheart Bio priced 18.75M shares at $16 to raise $300M on Nasdaq, funding its lead drug BHB-1893 for hypertrophic cardiomyopathy in the same week two other biotechs also priced.
Figma Stock Drops 16% Despite Revenue Beat
Figma Stock Drops 16% Despite Revenue Beat
Figma shares fell as much as 16.5% after Q2 revenue beat estimates at $370M but rising AI infrastructure costs and the departure of two senior executives overshadowed a raised full-year outlook.
SPAC Pipeline Grows With Two More Filings
SPAC Pipeline Grows With Two More Filings
Gravity Acquisition Corp continued toward its own listing and Alternus Clean Energy issued $14.28M of preferred stock ahead of a planned uplisting, extending the blank-check filing wave Pulse flagged earlier this week.
Why 217 IPOs Still Doesn't Mean the Window Is Open
Why 217 IPOs Still Doesn't Mean the Window Is Open
The US has produced 217 IPOs in 2026, up 6.9% year over year, and almost none of them are venture-backed technology companies -- which is why the count says nothing useful about exit liquidity.
AMD Beats Estimates, Stock Falls on Musk's Nvidia Bet
AMD Beats Estimates, Stock Falls on Musk's Nvidia Bet
AMD's Q2 results beat consensus and CEO Lisa Su guided to 80% server revenue growth in the second half, but shares fell after Elon Musk said SpaceX would commit fully to Nvidia chips for its AI infrastructure.
Goldman-Backed Attovia Prices IPO, Lists on Nasdaq
Goldman-Backed Attovia Prices IPO, Lists on Nasdaq
Attovia Therapeutics priced its IPO at $17/share, raising roughly $212.5M, and began trading on Nasdaq today under ATTO -- another test of whether biotech's IPO window is genuinely reopening.
Seven Blank-Check Deals Hit the Market in Three Days
Seven Blank-Check Deals Hit the Market in Three Days
Between August 3 and August 5, three SPACs priced at $10 a unit and four more filed or amended registration statements with the SEC -- the densest run of blank-check activity of the summer.
Uber Beats Q2 Bookings, Guides Q3 Below Estimates
Uber Beats Q2 Bookings, Guides Q3 Below Estimates
Uber's Q2 gross bookings of $58B topped estimates, but Q3 guidance for both bookings and EPS came in below consensus, sending shares down about 4%.
Attovia Prices $289M Nasdaq IPO at $17 a Share
Attovia Prices $289M Nasdaq IPO at $17 a Share
Attovia Therapeutics priced 17 million shares at $17 to raise $289M on Nasdaq under the ticker ATTO, the largest operating-company listing of the first week of August.
Uber Issues Weaker Q3 Outlook Despite Bookings Beat
Uber Issues Weaker Q3 Outlook Despite Bookings Beat
Uber's Q2 gross bookings beat estimates on World Cup travel demand, but Q3 bookings and earnings guidance came in below Wall Street's forecast, sending shares down more than 4% premarket.
Uber CEO Dismisses Reports of a Waymo Split
Uber CEO Dismisses Reports of a Waymo Split
Dara Khosrowshahi pushed back on reports that Uber and Waymo are heading for a breakup, on the same day Uber's stock fell on soft forward guidance and Zoox announced paid robotaxi rides in Las Vegas.
S&P 500, Stoxx 600 Both Hit Record Highs
S&P 500, Stoxx 600 Both Hit Record Highs
The S&P 500 closed at its first record high in two months and the Stoxx 600 touched an all-time high, both propelled by strong earnings and renewed AI-trade optimism despite this week's capex-driven sell-offs.
D-Wave Publishes a Quantum Error-Correction Advance
D-Wave Publishes a Quantum Error-Correction Advance
D-Wave published Nature research showing a fast, high-fidelity entangling gate for its dual-rail superconducting qubits, with simulations suggesting up to a tenfold cut in logical error rates per correction increment.
Robinhood Lists a Fund That Buys Y Combinator Stakes
Robinhood Lists a Fund That Buys Y Combinator Stakes
Robinhood Ventures Fund II is set to list publicly on August 13 at $25 a share, aiming to raise $200M so retail investors can indirectly back roughly 80 Y Combinator-linked private companies -- while paying Robinhood 2% and 20% carry.
Stoxx 600 Hits a Record as European Equities Rally
Stoxx 600 Hits a Record as European Equities Rally
Europe's benchmark index set an all-time high, extending a global equity rally that also carried the S&P 500 and Dow to records this week on strong earnings and easing oil prices.